Form 8-K - Current report:
SEC Accession No. 0001566469-24-000003
Filing Date
2024-01-02
Accepted
2024-01-02 16:25:48
Documents
13
Period of Report
2023-12-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K nh-20231226.htm   iXBRL 8-K 29064
5 nh-20231226_g1.jpg GRAPHIC 19217
  Complete submission text file 0001566469-24-000003.txt   199825

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nh-20231226.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nh-20231226_lab.xml EX-101.LAB 22877
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nh-20231226_pre.xml EX-101.PRE 11981
7 EXTRACTED XBRL INSTANCE DOCUMENT nh-20231226_htm.xml XML 2588
Mailing Address 3000 RDU CENTER DRIVE SUITE 200 MORRISVILLE NC 27560
Business Address 3000 RDU CENTER DRIVE SUITE 200 MORRISVILLE NC 27560 8559496288
NantHealth, Inc. (Filer) CIK: 0001566469 (see all company filings)

EIN.: 273019889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37792 | Film No.: 24502784
SIC: 7374 Services-Computer Processing & Data Preparation
(CF Office: 06 Technology)